NOV
58
-2
RCL
88
-2
ADI
45
-5
HPE
70
2
HCP
70
-4
IVZ
49
-3
PX
73
-6
NI
73
3
LRCX
46
-2
R
77
2
C
62
-3
AES
41
2
REGN
42
-2
RSG
77
4
BLK
70
-2
RIG
44
-2
SJM
16
-3
WFC
80
-2
LEN
52
2
UA
57
4
NOV
58
-2
RCL
88
-2
ADI
45
-5
HPE
70
2
HCP
70
-4
IVZ
49
-3
PX
73
-6
NI
73
3
LRCX
46
-2
R
77
2
C
62
-3
AES
41
2
REGN
42
-2
RSG
77
4
BLK
70
-2
RIG
44
-2
SJM
16
-3
WFC
80
-2
LEN
52
2
UA
57
4
Financhill
Back

Nuvalent Vs. Viking Therapeutics Industry Stock Comparison

Sell
36

NUVL
Nuvalent

Last Price:
90.23
Seasonality Move:
2.68%
Sell
40

VKTX
Viking Therapeutics

Last Price:
53.68
Seasonality Move:
48.88%
Sell
36
Nuvalent (NUVL) is a Sell

Is Nuvalent a Buy, Sell or Hold?

  • The current Nuvalent [NUVL] share price is $90.18. The Score for NUVL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • NUVL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $55.04. The Score for VKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NUVL Stock Price Chart

What is Nuvalent's stock price today?

  • The Nuvalent share price today is $90.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUVL is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $55.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

NUVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.59 Sell
Relative Strength Index (14 RSI): 40.67 Sell
Chaikin Money Flow: -368935 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.3 - 101.42) Sell
Bollinger Bands (100): (75.84 - 98.94) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.98 Sell
Relative Strength Index (14 RSI): 35.85 Sell
Chaikin Money Flow: -5799021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.4 - 71.92) Sell
Bollinger Bands (100): (53.94 - 67.22) Sell

NUVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.6 Sell
20-day SMA: 93.99 Sell
50-day SMA: 97.16 Sell
200-day SMA: 81.32 Buy
8-day EMA: 92.33 Sell
20-day EMA: 93.95 Sell
50-day EMA: 93.64 Sell
200-day EMA: 81.36 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.7 Sell
20-day SMA: 67.22 Sell
50-day SMA: 64.6 Sell
200-day SMA: 61.27 Sell
8-day EMA: 63.28 Sell
20-day EMA: 65.6 Sell
50-day EMA: 64.69 Sell
200-day EMA: 55.89 Sell

Nuvalent Earnings Growth & NUVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.58 per share, and a decrease next year of $0.47 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.

Nuvalent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):